Core Viewpoint - 蓝帆医疗 has established a partnership with 百心安 to promote the Iberis™ multi-polar renal denervation (RDN) system in international markets, showcasing its platform capabilities and industry recognition [1] Group 1: Partnership and Collaboration - 蓝帆医疗's subsidiary, 蓝帆柏盛, has quickly reached an "outbound" cooperation agreement with 百心安, enabling product promotion and market access in multiple overseas countries [1] - The overseas team of 蓝帆柏盛 not only handles sales functions but also assists in local market access and medical insurance communication, demonstrating effective collaboration with 百心安 [1] - The partnership model is deemed replicable for future endeavors, indicating a sustainable approach to international expansion [1] Group 2: Market Position and Strategy - 蓝帆柏盛 has become the largest overseas distributor for 深圳北芯生命科技, highlighting its platform capabilities and reinforcing its role in supporting the internationalization of innovative medical devices [1] - The company will determine the cooperation conditions for agency products based on product characteristics, competitive landscape, and target regions, indicating a strategic approach to market entry [1]